Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 117157
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.117157
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.117157
Table 1 Baseline comparison table in giant hepatic hemangioma group, mean ± SD/n (%)/median (interquartile rage)
| Liver subcapsular (n = 55) | Liver parenchymal (n = 17) | t/Z/χ2 | P value | |
| Age (years) | 48.00 ± 9.12 | 47.47 ± 7.54 | -0.217 | 0.829 |
| Sex | 0.872 | 0.350 | ||
| Female | 39 (72.72) | 10 (58.82) | ||
| Male | 16 (27.27) | 7 (41.18) | ||
| BMI | 24.26 ± 3.10 | 25.56 ± 3.48 | 1.469 | 0.146 |
| Size (cm) | 10.83 (10.33-13.80) | 10.50 (10.11-10.90) | -1.711 | 0.087 |
| Location of main lesion | 3.535 | 0.060 | ||
| Left lobe | 18 (30.91) | 1 (5.88) | ||
| Right lobe | 37 (69.09) | 16 (94.12) | ||
| Hepatitis B virus | 3 (5.45) | 0 (0) | ||
| Reasons for operation | 0.062 | 0.804 | ||
| Symptomatic | 10 (18.2) | 2 (11.8) | ||
| Enlargement | 45 (81.8) | 15 (88.2) | ||
| Number of lesions | 2.103 | 0.349 | ||
| 1 | 19 (34.5) | 8 (47.1) | ||
| 2 | 9 (16.4) | 4 (23.5) | ||
| Multiple | 27 (49.1) | 5 (29.4) | ||
| Inflammatory | ||||
| WBC (109/L) | 5.34 ± 1.82 | 5.06 ± 1.30 | -0.581 | 0.563 |
| Neutrophil (%) | 57.60 (49.43-62.25) | 55.40 (49.28-63.80) | -1.048 | 0.295 |
| Hb (g/L) | 127.65 ± 21.51 | 135.29 ± 17.14 | 1.337 | 0.186 |
| Liver function | ||||
| TB (μmol/L) | 12.54 ± 4.56 | 12.41 ± 5.72 | -0.101 | 0.920 |
| ALT (U/L) | 15.30 (10.25-28.00) | 24.5 (11.75-42.75) | -1.533 | 0.125 |
| AST (U/L) | 15.50 (14.00-19.75) | 20.50 (16.25-26.50) | -1.920 | 0.055 |
| GGT (U/L) | 18.00 (11.25-33.75) | 37.00 (17.75-54.50) | -1.360 | 0.174 |
| Coagulation | ||||
| PT (seconds) | 11.62 ± 0.72 | 11.69 ± 1.30 | 0.299 | 0.766 |
| D-D (μg/L) | 292.00 (145.75-828.25) | 242.50 (141.00-526.50) | -0.945 | 0.345 |
| Renal function | ||||
| Cr (μmol/L) | 65.30 ± 13.40 | 67.41 ± 10.76 | 0.591 | 0.556 |
| BUN (mg/dL) | 4.86 ± 1.21 | 4.79 ± 1.12 | -0.207 | 0.837 |
Table 2 Baseline comparison table in large hepatic hemangioma group, mean ± SD/n (%)/median (interquartile rage)
| Liver subcapsular (n = 63) | Liver parenchymal (n = 17) | t/Z/χ2 | P value | |
| Age (years) | 46.92 ± 10.762 | 46.29 ± 11.22 | -0.211 | 0.833 |
| Sex | 0.000 | 1.000 | ||
| Male | 14 (22.2) | 4 (23.5) | ||
| Female | 49 (77.8) | 13 (76.5) | ||
| BMI | 24.44 ± 3.07 | 24.68 ± 4.58 | -0.731 | 0.803 |
| Size (cm) | 7.20 ± 1.24 | 6.94 ± 1.18 | 0.782 | 0.436 |
| Location of main lesion | 1.396 | 0.237 | ||
| Left lobe | 14 (22.2) | 1 (5.88) | ||
| Right lobe | 49 (77.8) | 16 (94.12) | ||
| Number of lesions | 0.720 | 0.698 | ||
| 1 | 25 (39.7) | 7 (41.2) | ||
| 2 | 10 (15.9) | 4 (23.5) | ||
| Multiple | 28 (44.4) | 6 (35.3) | ||
| Hepatitis B virus | 1 (1.59) | 0 (0) | ||
| Reasons for operation | 0.990 | |||
| Symptomatic | 5 (7.9) | 2 (11.8) | ||
| Enlargement | 58 (92.1) | 15 (88.2) | ||
| Inflammatory | ||||
| WBC (109/L) | 5.26 ± 1.60 | 5.75 ± 1.61 | -1.126 | 0.297 |
| Neutrophil (%) | 128.22 ± 15.58 | 134.12 ± 12.65 | -1.436 | 0.155 |
| Hb (g/L) | 51.40 (47.18-59.85) | 50.95 (46.08-61.18) | -0.112 | 0.911 |
| Liver function | ||||
| TB (μmol/L) | 14.08 ± 13.41 | 13.21 ± 6.10 | 0.258 | 0.797 |
| ALT (U/L) | 12.00 (10.00-15.75) | 13.30 (11.00-16.75) | -0.807 | 0.420 |
| AST (U/L) | 15.00 (13.00-16.75) | 15.00 (12.88-19.00) | -0.605 | 0.545 |
| GGT (U/L) | 15.00 (13.00-19.50) | 25.50 (14.00-31.50) | -1.434 | 0.152 |
| Coagulation | ||||
| PT (seconds) | 11.54 ± 0.59 | 11.88 ± 1.16 | -1.656 | 0.102 |
| D-D (μg/L) | 155.50 (133.25-214.50) | 183.00 (88.75-545.00) | -0.957 | 0.338 |
| Renal function | ||||
| Cr (μmol/L) | 65.30 ± 11.22 | 62.35 ± 14.42 | 0.902 | 0.370 |
| BUN (mg/dL) | 4.81 ± 1.42 | 4.86 ± 1.49 | -0.130 | 0.897 |
Table 3 Compare the postoperative recovery conditions of the liver subcapsular group and the liver parenchymal group in the large hepatic hemangioma group, mean ± SD/median (interquartile rage)
| Liver subcapsular (n = 63) | Liver parenchymal (n = 17) | t/Z/χ2 | P value | |
| Inflammatory | ||||
| WBC (109/L) | 9.61 ± 2.83 | 9.14 ± 2.84 | 0.607 | 0.545 |
| Neutrophil (%) | 83.13 ± 6.67 | 80.85 ± 8.96 | 1.162 | 0.249 |
| Liver function | ||||
| TB (μmol/L) | 31.17 ± 14.06 | 31.41 ± 10.21 | -0.066 | 0.948 |
| ALT (U/L) | 281.70 (180.95-452.83) | 328.95 (191.15-596.55) | -0.747 | 0.455 |
| AST (U/L) | 413.30 (251.15-617.20) | 318.50 (221.43-705.93) | -0.006 | 0.955 |
| GGT (U/L) | 24.50 (17.25-39.75) | 43.50 (22.75-68.50) | -1.808 | 0.071 |
| Renal function | ||||
| Cr (μmol/L) | 53.95 (47.65-64.58) | 58.50 (50.43-65.65) | -0.968 | 0.333 |
| BUN (mg/dL) | 3.30 (2.60-3.98) | 3.65 (2.82-4.25) | -0.341 | 0.733 |
| Coagulation | ||||
| PT (seconds) | 12.18 ± 0.64 | 12.70 ± 0.56 | -3.026 | 0.003 |
| D-D (μg/L) | 2026 (1158-2534) | 2403 (2001-2645) | -1.607 | 0.108 |
| Perioperative | ||||
| Ablation time (minutes) | 32.82 ± 9.50 | 32.36 ± 9.20 | 0.167 | 0.868 |
| Clinical stay (day) | 3.00 (3.00-3.00) | 3.00 (3.00-4.00) | -0.721 | 0.471 |
| Exhaust time (day) | 1.00 (1.00-2.00) | 1.50 (1.00-2.00) | -0.431 | 0.667 |
| Surgical blood loss (mL) | 10.00 (9.00-20.00) | 5.00 (5.00-10.00) | -2.053 | 0.040 |
| Spent | 61352 (47405-65220) | 56366 (47355-60906) | -0.489 | 0.625 |
Table 4 Compare the postoperative recovery conditions of the liver subcapsular group and the liver parenchymal group in the giant hepatic hemangioma group, mean ± SD/median (interquartile rage)
| Liver subcapsular (n = 55) | Liver parenchymal (n = 17) | t/Z/χ2 | P value | |
| Inflammatory | ||||
| WBC (109/L) | 9.98 ± 3.58 | 9.58 ± 3.03 | 0.408 | 0.685 |
| Neutrophil (%) | 86.40 (81.50-89.95) | 85.00 (80.25-90.85) | -0.097 | 0.923 |
| Liver function | 2.00 (2.00-2.00) | 2.00 (1.50-2.50) | -0.885 | 0.376 |
| TB (μmol/L) | 41.60 (25.05-54.05) | 38.70 (24.70-52.25) | -0.225 | 0.822 |
| ALT (U/L) | 237.60 (157.30-473.90) | 338.60 (261.75-418.75) | -1.492 | 0.136 |
| AST (U/L) | 498.80 (284.75-685.65) | 482.20 (381.70-640.35) | -0.577 | 0.564 |
| GGT (U/L) | 40.00 (24.00-46.50) | 47.00 (23.50-60.50) | -0.736 | 0.462 |
| Renal function | ||||
| Cr (μmol/L) | 56.20 (47.60-65.82) | 58.1 (48.90-68.25) | -0.245 | 0.806 |
| BUN (mg/dL) | 4.40 (3.60-5.40) | 4.00 (3.30-4.95) | -0.763 | 0.445 |
| Coagulation | ||||
| PT (seconds) | 12.72 (12.40-12.72) | 12.58 (12.00-13.10) | -1.152 | 0.249 |
| D-D (μg/L) | 2822 (1597-2822) | 1936 (1442-3131) | -1.506 | 0.132 |
| Perioperative | ||||
| Ablation time (minutes) | 50.09 ± 14.48 | 43.71 ± 10.89 | 1.671 | 0.099 |
| Clinical stay (day) | 3.00 (3.00-4.00) | 3.00 (2.00-4.00) | -1.010 | 0.312 |
| Spent | 60455 (57106-64849) | 60716 (56262-62966) | -0.166 | 0.868 |
| Exhaust time (day) | 2 (2-3) | 1.5 (1.25-2.5) | -0.885 | 0.376 |
| Surgical blood loss (mL) | 20.00 (10.00-50.00) | 20.00 (10.00-35.00) | -0.097 | 0.923 |
Table 5 Compare the postoperative recovery conditions of the giant hepatic hemangioma and large hepatic hemangioma groups in the liver parenchymal group, mean ± SD/median (interquartile rage)
| GHH (n = 17) | LHH (n = 17) | t/Z/χ2 | P value | |
| Inflammatory | ||||
| WBC (109/L) | 9.58 ± 3.03 | 9.14 ± 2.84 | 0.441 | 0.662 |
| Neutrophil (%) | 85.00 (80.25-89.93) | 82.40 (73.75-89.70) | -1.051 | 0.293 |
| Liver function | ||||
| TB (μmol/L) | 42.61 ± 23.37 | 31.41 ± 10.21 | 1.809 | 0.080 |
| ALT (U/L) | 375.63 ± 157.13 | 378.32 ± 234.54 | -0.039 | 0.969 |
| AST (U/L) | 559.81 ± 257.56 | 479.50 ± 337.71 | 0.780 | 0.441 |
| GGT (U/L) | 41.00 (19.50-79.75) | 42.50 (25.75-63.00) | -0.689 | 0.491 |
| Renal function | ||||
| Cr (μmol/L) | 59.50 (52.60-65.50) | 58.1 (48.90-68.25) | -0.362 | 0.718 |
| BUN (mg/dL) | 5.60 (3.33-12.38) | 3.35 (2.95-4.07) | -1.758 | 0.079 |
| Coagulation | ||||
| D-D (μg/L) | 1935.05 ± 1315.62 | 2403.25 ± 2441.19 | -1.003 | 0.596 |
| PT (seconds) | 12.58 ± 1.12 | 12.70 ± 0.85 | -0.449 | 0.793 |
| Perioperative | ||||
| Spent | 60716.60 (56261.64-62966.02) | 56527.12 (47523.46-60886.15) | -1.705 | 0.088 |
| Ablation time (minutes) | 43.71 ± 10.89 | 32.29 ± 8.29 | 3.438 | 0.002 |
| Exhaust time (day) | 2.00 (1.25-2.75) | 1.50 (1.00-2.00) | -2.925 | 0.003 |
| Surgical blood loss (mL) | 30.00 (6.25-50.00) | 15.00 (6.25-42.50) | -2.553 | 0.011 |
| Clinical stay (day) | 3.00 (2.00-4.00) | 3.00 (3.00-4.00) | -0.829 | 0.407 |
Table 6 Compare the postoperative recovery conditions of the giant hepatic hemangioma and large hepatic hemangioma groups within the liver subcapsular group, mean ± SD/median (interquartile rage)
| GHH (n = 55) | LHH (n = 63) | t/Z/χ2 | P value | |
| Inflammatory | ||||
| WBC (109/L) | 85.58 ± 6.13 | 83.11 ± 6.67 | 2.071 | 0.041 |
| Neutrophil (%) | 9.98 ± 3.58 | 9.61 ± 2.83 | 0.618 | 0.538 |
| Liver function | ||||
| TB (μmol/L) | 39.35 (26.30-55.60) | 32.10 (22.23-37.23) | -3.067 | 0.002 |
| ALT (U/L) | 201.40 (131.40-372.95) | 280.55 (181.88-460.90) | -0.310 | 0.756 |
| AST (U/L) | 462.40 (240.05-626.98) | 396.35 (271.80-647.13) | -1.387 | 0.165 |
| GGT (U/L) | 38.00 (22.25-61.75) | 22.00 (15.00-27.25) | -2.928 | 0.003 |
| Renal function | ||||
| Cr (μmol/L) | 61.15 (44.65-88.10) | 55.75 (47.80-64.58) | -0.758 | 0.448 |
| BUN (mg/dL) | 4.89 (3.85-6.37) | 3.60 (2.80-3.98) | -4.466 | < 0.001 |
| Coagulation | ||||
| D-D (μg/L) | 1909.50 (996.25-5124.50) | 1339.50 (719.50-3002.00) | -2.485 | 0.013 |
| PT (seconds) | 12.72 (12.40-12.72) | 12.18 (11.90-15.50) | -3.985 | < 0.001 |
| Perioperative | ||||
| Spent | 60846.12 (53898.31-64930.00) | 55564.91 (36598.66-62983.01) | -1.513 | 0.130 |
| Exhaust time (day) | 2.00 (2.00-2.00) | 1.00 (1.00-2.00) | -4.606 | < 0.001 |
| Ablation time (minutes) | 50.00 (40.00-60.00) | 30.50 (28.00-37.75) | -6.346 | < 0.001 |
| Clinical stay (day) | 3.00 (3.00-4.00) | 3.00 (2.00-3.00) | -1.361 | 0.173 |
| Surgical blood loss (mL) | 20.00 (10.00-45.00) | 10.00 (5.25-20.00) | -2.179 | 0.029 |
Table 7 Comparison of postoperative complications between giant hepatic hemangioma and large hepatic hemangioma groups, n (%)
| GHH (n = 72) | LHH (n = 80) | χ2 | P value | |
| Anemia | 19 (26.39) | 12 (15) | 3.027 | 0.082 |
| Fever | 40 (55.56) | 8 (10) | 36.398 | < 0.001 |
| Hemoglobinuria | 8 (11.11) | 9 (11.25) | 0.001 | 0.987 |
| Acute kidney injury | 1 (1.39) | 1 (1.25) | 1.000 | |
| Hypoproteinemia | 3 (4.17) | 0 (0) | 4.550 | 0.033 |
Table 8 Comparison of postoperative complications between liver subcapsular and liver parenchymal groups, n (%)
| Liver subcapsular (n = 118) | Liver parenchymal (n = 34) | χ2 | P value | |
| Anemia | 23 (19.49) | 8 (23.53) | 0.265 | 0.607 |
| Fever | 31 (26.27) | 17 (50) | 6.878 | 0.009 |
| Hemoglobinuria | 15 (12.71) | 1 (2.94) | 1.739 | 0.187 |
| Acute kidney injury | 1 (0.8) | 1 (2.94) | 0.398 | |
| Hypoproteinemia | 2 (1.69) | 1 (2.94) | 0.535 |
- Citation: Wu CL, Chen XC, Zhao W, Hu B, Huan HB, Tu YL, Zhu ZM, Jiang K. Laparoscopic microwave ablation for hepatic hemangiomas with different locations: A comparative study. World J Hepatol 2026; 18(5): 117157
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/117157.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.117157